The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation

Cytokine

Volumn 54, Issue 1, 2011, Pages 6-19

  Tsukada, Junichi ^a   Yoshida, Yasuhiro ^b   Kominato, Yoshihiko ^c   Auron, Philip E ^d  

^a School of Medicine   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c GUNMA UNIVERSITY   (Japan)

^d DUQUESNE UNIVERSITY   (United States)

Author keywords

BZIP family; C EBP; CCAAT enhancer binding proteins; Transcription factors

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; CCAAT ENHANCER BINDING PROTEIN EPSILON; CCAAT ENHANCER BINDING PROTEIN ZETA; ISOPROTEIN; MYELOID DIFFERENTIATION FACTOR 88; NUCLEIC ACID BINDING PROTEIN; PROTEIN C MYB; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ACETYLATION; ACUTE PHASE RESPONSE; BINDING SITE; BONE DEVELOPMENT; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; COMPLEX FORMATION; CYTOKINE RESPONSE; DIMERIZATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INDUCTION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; IMMUNOREGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY SEQUENCE; REVIEW; SIGNAL TRANSDUCTION; SUMOYLATION; TRANSLATION INITIATION; TRANSLATION REGULATION;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; DIMERIZATION; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 79952073585     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.12.019     Document Type: Review

References (137)

1. Ptashne M. How eukaryotic transcriptional activators work. Nature 1988, 335:683-689.
2. Dynan W.S. Modularity in promoters and enhancers. Cell 1989, 58:1-4.
3. Lamb P., McKnight S.L. Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerization. Trends Biochem Sci 1991, 16:417-422.
4. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002, 365:561-575.
5. Johnson P.F. Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J Cell Sci 2005, 118:2545-2555.
6. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 2007, 17:318-324.
7. Koschmieder S., Halmos B., Levantini E., Tenen D.G. Dysregulation of the C/EBPalpha differentiation pathway in human cancer. J Clin Oncol 2009, 27:619-628.
8. Nerlov C. C/EBPs: recipients of extracellular signals through proteome modulation. Curr Opin Cell Biol 2008, 20:180-185.
9. Khanna-Gupta A. Sumoylation and the function of CCAAT enhancer binding protein alpha (C/EBP alpha). Blood Cells Mol Dis 2008, 41:77-81.
10. Li H., Gade P., Xiao W., Kalvakolanu D.V. The interferon signaling network and transcription factor C/EBP-beta. Cell Mol Immunol 2007, 4:407-418.
11. Smink J.J., Leutz A. Rapamycin and the transcription factor C/EBPβ as a switch in osteoclast differentiation: implications for lytic bone diseases. J Mol Med 2009, 88:227-233.
12. Friedman A.D. Transcriptional control of granulocyte and monocyte development. Oncogene 2007, 26:6816-6828.
13. Cassel T.N., Nord M. C/EBP transcription factors in the lung epithelium. Am J Physiol Lung Cell Mol Physiol 2003, 285:L773-L781.
14. Centrella M., Christakos S., McCarthy T.L. Skeletal hormones and the C/EBP and Runx transcription factors: interactions that integrate and redefine gene expression. Gene 2004, 342:13-24.
15. Darlington G.J., Ross S.E., MacDougald O.A. The role of C/EBP genes in adipocyte differentiation. J Biol Chem 1998, 273:30057-30060.
16. Takiguchi M. The C/EBP family of transcription factors in the liver and other organs. Int J Exp Pathol 1998, 79:369-391.
17. Liu Y., Nonnemacher M.R., Wigdahl B. CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection. Future Microbiol 2009, 4:299-321.
18. Landschulz W.H., Johnson P.F., McKnight S.L. The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. Science 1989, 243:1681-1688.
19. LaCasse E.C., Lefebvre Y.A. Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins. Nucleic Acids Res 1995, 23:1647-1656.
20. Williams S.C., Angerer N.D., Johnson P.F. C/EBP proteins contain nuclear localization signals imbedded in their basic regions. Gene Expr 1997, 6:371-385.
21. Katz S., Kowenz-Leutz E., Muller C., Meese K., Ness S.A., Leutz A. The NF-M transcription factor is related to C/EBP beta and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells. EMBO J 1993, 12:1321-1332.
22. Miller M., Shuman J.D., Sebastian T., Dauter Z., Johnson P.F. Structural basis for DNA recognition by the basic region leucine zipper transcription factor CCAAT/enhancer-binding protein alpha. J Biol Chem 2003, 278:15178-15184.
23. Petosa C., Morand P., Baudin F., Moulin M., Artero J.B., Muller C.W. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol Cell 2006, 21:565-572.
24. Tahirov T.H., Sato K., Ichikawa-Iwata E., Sasaki M., Inoue-Bungo T., Shiina M., et al. Mechanism of c-Myb-C/EBP β cooperation from separated sites on a promoter. Cell 2002, 108:57-70.
25. Listman J.A., Wara-aswapati N., Race J.E., Blystone L.W., Walker-Kopp N., Yang Z., et al. Conserved ETS domain arginines mediate DNA binding, nuclear localization, and a novel mode of bZIP interaction. J Biol Chem 2005, 280:41421-41428.
26. Cao Z., Umek R.M., McKnight S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991, 5:1538-1552.
27. Kowenz-Leutz E., Twamley G., Ansieau S., Leutz A. Novel mechanism of C/EBP beta (NF-M) transcriptional control: activation through derepression. Genes Dev 1994, 8:2781-2791.
28. Williams S.C., Baer M., Dillner A.J., Johnson P.F. CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO J 1995, 14:3170-3183.
29. Natsuka S., Akira S., Nishio Y., Hashimoto S., Sugita T., Isshiki H., et al. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6. Blood 1992, 79:460-466.
30. Morosetti R., Park D.J., Chumakov A.M., Grillier I., Shiohara M., Gombart A.F., et al. A novel, myeloid transcription factor, C/EBPε, is upregulated during granulocytic, but not monocytic, differentiation. Blood 1997, 90:2591-2600.
31. Roman C., Platero J.S., Shuman J., Calame K. Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP. Genes Dev 1990, 4:1404-1415.
32. Glover J.N., Harrison S.C. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 1995, 373:257-261.
33. Tahirov T.H., Inoue-Bungo T., Morii H., Fujikawa A., Sasaki M., Kimura K., et al. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFβ. Cell 2001, 104:755-767.
34. Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. Embo J 1990, 9:1897-1906.
35. Dunn S.M., Coles L.S., Lang R.K., Gerondakis S., Vadas M.A., Shannon M.F. Requirement for nuclear factor (NF)-kappa B p65 and NF-interleukin-6 binding elements in the tumor necrosis factor response region of the granulocyte colony-stimulating factor promoter. Blood 1994, 83:2469-2479.
36. Matsumoto M., Sakao Y., Akira S. Inducible expression of nuclear factor IL-6 increases endogenous gene expression of macrophage inflammatory protein-1 alpha, osteopontin and CD14 in a monocytic leukemia cell line. Int Immunol 1998, 10:1825-1835.
37. Alam T., An M.R., Mifflin R.C., Hsieh C.C., Ge X., Papaconstantinou J. Trans-activation of the alpha 1-acid glycoprotein gene acute phase responsive element by multiple isoforms of C/EBP and glucocorticoid receptor. J Biol Chem 1993, 268:15681-15688.
38. Ray B.K., Ray A. Expression of the gene encoding alpha 1-acid glycoprotein in rabbit liver under acute-phase conditions involves induction and activation of beta and delta CCAAT-enhancer-binding proteins. Eur J Biochem 1994, 222:891-900.
39. Nishio Y., Isshiki H., Kishimoto T., Akira S. A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction. Mol Cell Biol 1993, 13:1854-1862.
40. Ryden T.A., Beemon K. Avian retroviral long terminal repeats bind CCAAT/enhancer-binding protein. Mol Cell Biol 1989, 9:1155-1164.
41. Osada S., Yamamoto H., Nishihara T., Imagawa M. DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. J Biol Chem 1996, 271:3891-3896.
42. Mahony S., Auron P.E., Benos P.V. DNA familial binding profiles made easy: comparison of various motif alignment and clustering strategies. PLoS Comput Biol 2007, 3:578-591.
43. Craig J.C., Schumacher M.A., Mansoor S.E., Farrens D.L., Brennan R.G., Goodman R.H. Consensus and variant cAMP-regulated enhancers have distinct CREB-binding properties. J Biol Chem 2001, 276:11719-11728.
44. Metallo S.J., Schepartz A. Certain bZIP peptides bind DNA sequentially as monomers and dimerize on the DNA. Nat Struct Biol 1997, 4:115-117.
45. Kohler J.J., Metallo S.J., Schneider T.L., Schepartz A. DNA specificity enhanced by sequential binding of protein monomers. Proc Natl Acad Sci USA 1999, 96:11735-11739.
46. Hollenbeck J.J., Oakley M.G. GCN4 binds with high affinity to DNA sequences containing a single consensus half-site. Biochemistry 2000, 39:6380-6389.
47. Newman J.R., Keating A.E. Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 2003, 300:2097-2101.
48. Ron D., Habener J.F. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 1992, 6:439-453.
49. Hattori T., Ohoka N., Hayashi H., Onozaki K. C/EBP homologous protein (CHOP) up-regulates IL-6 transcription by trapping negative regulating NF-IL6 isoform. FEBS Lett 2003, 541:33-39.
50. Ubeda M., Vallejo M., Habener J.F. CHOP enhancement of gene transcription by interactions with Jun/Fos AP-1 complex proteins. Mol Cell Biol 1999, 19:7589-7599.
51. Ubeda M., Wang X.Z., Zinszner H., Wu I., Habener J.F., Ron D. Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Mol Cell Biol 1996, 16:1479-1489.
52. Wang X.Z., Kuroda M., Sok J., Batchvarova N., Kimmel R., Chung P., et al. Identification of novel stress-induced genes downstream of chop. Embo J 1998, 17:3619-3630.
53. Caristi S., Piraino G., Cucinotta M., Valenti A., Loddo S., Teti D. Prostaglandin E2 induces interleukin-8 gene transcription by activating C/EBP homologous protein in human T lymphocytes. J Biol Chem 2005, 280:14433-14442.
54. Cucinotta M., Visalli M., Aguennouz M., Valenti A., Loddo S., Altucci L., et al. Regulation of interleukin-8 gene at a distinct site of its promoter by CCAAT enhancer-binding protein homologous protein in prostaglandin E2-treated human T cells. J Biol Chem 2008, 283:29760-29769.
55. Cooper C., Henderson A., Artandi S., Avitahl N., Calame K. Ig/EBP (C/EBP γ) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Res 1995, 23:4371-4377.
56. Hu H.M., Tian Q., Baer M., Spooner C.J., Williams S.C., Johnson P.F., et al. The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J Biol Chem 2000, 275:16373-16381.
57. Gao H., Parkin S., Johnson P.F., Schwartz R.C. C/EBP γ has a stimulatory role on the IL-6 and IL-8 promoters. J Biol Chem 2002, 277:38827-38837.
58. Parkin S.E., Baer M., Copeland T.D., Schwartz R.C., Johnson P.F. Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBP (Ig/EBP). J Biol Chem 2002, 277:23563-23572.
59. Vallejo M., Ron D., Milller C.P., Habener J.F. C/ATF, a member of the activating transcription factor family of DNA-binding proteins, dimerizes ith CAAT/enhancer-binding proteins and directs their binding to cAMP response elements. Proc Natl Acad Sci USA 1993, 90:4679-4683.
60. Vinson C.R., Hai T., Boyd S.M. Dimerization specificity of the leucine zipper-containing bZIP motif on DNA binding: prediction and rational design. Genes Dev 1993, 7:1047-1058.
61. Tsukada J., Saito K., Waterman W.R., Webb A.C., Auron P.E. Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1β gene. Mol Cell Biol 1994, 14:7285-7297.
62. Podust L.M., Krezel A.M., Kim Y. Crystal structure of the CCAAT box/enhancer-binding protein β activating transcription factor-4 basic leucine zipper heterodimer in the absence of DNA. J Biol Chem 2001, 276:505-513.
63. Gombart A.F., Grewal J., Koeffler H.P. ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha. J Leukoc Biol 2007, 81:1535-1547.
64. Tominaga H., Maeda S., Hayashi M., Takeda S., Akira S., Komiya S., et al. CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4. Mol Biol Cell 2008, 19:5373-5386.
65. Chandra G., Cogswell J.P., Miller L.R., Godlevski M.M., Stinnett S.W., Noel S.L., et al. Cyclic AMP signaling pathways are important in IL-1β transcriptional regulation. J Immunol 1995, 155:4535-4543.
66. Gale R.P., Horowitz M.M., Rees J.K., Gray R.G., Oken M.M., Estey E.H., et al. Chemotherapy versus transplants for acute myelogenous leukemia in second remission. Leukemia 1996, 10:13-19.
67. Weiss M.A., Ellenberger T., Wobbe C.R., Lee J.P., Harrison S.C., Struhl K. Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA. Nature 1990, 347:575-578.
68. Chen B.P., Wolfgang C.D., Hai T. Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop10. Mol Cell Biol 1996, 16:1157-1168.
69. Su N., Kilberg M.S. C/EBP homology protein (CHOP) interacts with activating transcription factor 4 (ATF4) and negatively regulates the stress-dependent induction of the asparagine synthetase gene. J Biol Chem 2008, 283:35106-35117.
70. Ohoka N., Yoshii S., Hattori T., Onozaki K., Hayashi H. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. Embo J 2005, 24:1243-1255.
71. Lopez A.B., Wang C., Huang C.C., Yaman I., Li Y., Chakravarty K., et al. A feedback transcriptional mechanism controls the level of the arginine/lysine transporter cat-1 during amino acid starvation. Biochem J 2007, 402:163-173.
72. Gjymishka A., Palii S.S., Shan J., Kilberg M.S. Despite increased ATF4 binding at the C/EBP-ATF composite site following activation of the unfolded protein response, system A transporter 2 (SNAT2) transcription activity is repressed in HepG2 cells. J Biol Chem 2008, 283:27736-27747.
73. Fawcett T.W., Martindale J.L., Guyton K.Z., Hai T., Holbrook N.J. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem J 1999, 339(Pt 1):135-141.
74. Calkhoven C.F., Muller C., Leutz A. Translational control of C/EBPα and C/EBPβ isoform expression. Genes Dev 2000, 14:1920-1932.
75. Descombes P., Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991, 67:569-579.
76. Calkhoven C.F., Bouwman P.R., Snippe L., Ab G. Translation start site multiplicity of the CCAAT/enhancer binding protein α mRNA is dictated by a small 5′ open reading frame. Nucleic Acids Res 1994, 22:5540-5547.
77. Lincoln A.J., Monczak Y., Williams S.C., Johnson P.F. Inhibition of CCAAT/enhancer-binding protein alpha and beta translation by upstream open reading frames. J Biol Chem 1998, 273:9552-9560.
78. Muller C., Bremer A., Schreiber S., Eichwald S., Calkhoven C.F. Nucleolar retention of a translational C/EBPα isoform stimulates rDNA transcription and cell size. Embo J 2010, 29:897-909.
79. Smink J.J., Begay V., Schoenmaker T., Sterneck E., de Vries T.J., Leutz A. Transcription factor C/EBPβ isoform ratio regulates osteoclastogenesis through MafB. Embo J 2009, 28:1769-1781.
80. Smink J.J., Leutz A. Rapamycin and the transcription factor C/EBPbeta as a switch in osteoclast differentiation: implications for lytic bone diseases. J Mol Med 2010, 88:227-233.
81. Wethmar K., Begay V., Smink J.J., Zaragoza K., Wiesenthal V., Dorken B., et al. C/EBPβΔORF mice-a genetic model for uORF-mediated translational control in mammals. Genes Dev 2010, 24:15-20.
82. Uematsu S., Kaisho T., Tanaka T., Matsumoto M., Yamakami M., Omori H., et al. The C/EBP beta isoform 34-kDa LAP is responsible for NF-IL-6-mediated gene induction in activated macrophages, but is not essential for intracellular bacteria killing. J Immunol 2007, 179:5378-5386.
83. Ma X., Riemann H., Gri G., Trinchieri G. Positive and negative regulation of interleukin-12 gene expression. Eur Cytokine Netw 1998, 9:54-64.
84. Plevy S.E., Gemberling J.H., Hsu S., Dorner A.J., Smale S.T. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol Cell Biol 1997, 17:4572-4588.
85. Gorgoni B., Maritano D., Marthyn P., Righi M., Poli V. C/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages. J Immunol 2002, 168:4055-4062.
86. Mahoney C.W., Shuman J., McKnight S.L., Chen H.C., Huang K.P. Phosphorylation of CCAAT-enhancer binding protein by protein kinase C attenuates site-selective DNA binding. J Biol Chem 1992, 267:19396-19403.
87. Trautwein C., van der Geer P., Karin M., Hunter T., Chojkier M. Protein kinase A and C site-specific phosphorylations of LAP (NF-IL6) modulate its binding affinity to DNA recognition elements. J Clin Invest 1994, 93:2554-2561.
88. Ross S.E., Radomska H.S., Wu B., Zhang P., Winnay J.N., Bajnok L., et al. Phosphorylation of C/EBPalpha inhibits granulopoiesis. Mol Cell Biol 2004, 24:675-686.
89. Chumakov A.M., Silla A., Williamson E.A., Koeffler H.P. Modulation of DNA binding properties of CCAAT/enhancer binding protein ε by heterodimer formation and interactions with NFκB pathway. Blood 2007, 109:4209-4219.
90. LeClair K.P., Blanar M.A., Sharp P.A. The p50 subunit of NF-κB associates with the NF-IL6 transcription factor. Proc Natl Acad Sci USA 1992, 89:8145-8149.
91. Hanlon M., Sturgill T.W., Sealy L. ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor. J Biol Chem 2001, 276:38449-38456.
92. Nakajima T., Kinoshita S., Sasagawa T., Sasaki K., Naruto M., Kishimoto T., et al. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci USA 1993, 90:2207-2211.
93. Cloutier A., Guindi C., Larivee P., Dubois C.M., Amrani A., McDonald P.P. Inflammatory cytokine production by human neutrophils involves C/EBP transcription factors. J Immunol 2009, 182:563-571.
94. Ramirez-Carrozzi V.R., Nazarian A.A., Li C.C., Gore S.L., Sridharan R., Imbalzano A.N., et al. Selective and antagonistic functions of SWI/SNF and Mi-2β nucleosome remodeling complexes during an inflammatory response. Genes Dev 2006, 20:282-296.
95. Borland G., Bird R.J., Palmer T.M., Yarwood S.J. Activation of protein kinase Cα by EPAC1 is required for the ERK- and CCAAT/enhancer-binding protein β-dependent induction of the SOCS-3 gene by cyclic AMP in COS1 cells. J Biol Chem 2009, 284:17391-17403.
96. Wegner M., Cao Z., Rosenfeld M.G. Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta. Science 1992, 256:370-373.
97. Trautwein C., Caelles C. Van dGP, Hunter T, Karin M, Chojkier M. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain. Nature 1993, 364:544-547.
98. Buck M., Poli V., van der Geer P., Chojkier M., Hunter T. Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha. Mol Cell 1999, 4:1087-1092.
99. Buck M., Zhang L., Halasz N.A., Hunter T., Chojkier M. Nuclear export of phosphorylated C/EBPbeta mediates the inhibition of albumin expression by TNF-alpha. EMBO J 2001, 20:6712-6723.
100. Tang Q.Q., Gronborg M., Huang H., Kim J.W., Otto T.C., Pandey A., et al. Sequential phosphorylation of CCAAT enhancer-binding protein β by MAPK and glycogen synthase kinase 3β is required for adipogenesis. Proc Natl Acad Sci USA 2005, 102:9766-9771.
101. Li X., Kim J.W., Gronborg M., Urlaub H., Lane M.D., Tang Q.Q. Role of cdk2 in the sequential phosphorylation/activation of C/EBPβ during adipocyte differentiation. Proc Natl Acad Sci USA 2007, 104:11597-11602.
102. Kim J.W., Tang Q.Q., Li X., Lane M.D. Effect of phosphorylation and S-S bond-induced dimerization on DNA binding and transcriptional activation by C/EBPβ. Proc Natl Acad Sci USA 2007, 104:1800-1804.
103. Park Y.K., Park H. Prevention of CCAAT/enhancer-binding protein β DNA binding by hypoxia during adipogenesis. J Biol Chem 2010, 285:3289-3299.
104. Shen F, Li N, Gade P, Kalvakolanu DV, Weibley T, Doble B, Woodgett JR, Wood TD, Gaffen SL. IL-17 receptor signaling inhibits C/EBPβ by sequential phosphorylation of the regulatory 2 domain. Sci Signal 2009; 2: ra8.
105. Radomska H.S., Basseres D.S., Zheng R., Zhang P., Dayaram T., Yamamoto Y., et al. Block of C/EBP alpha function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J Exp Med 2006, 203:371-381.
106. Tjian R., Maniatis T. Transcriptional activation: a complex puzzle with few easy pieces. Cell 1994, 77:5-8.
107. Weis L., Reinberg D. Transcription by RNA polymerase II: initiator-directed formation of transcription-competent complexes. Faseb J 1992, 6:3300-3309.
108. Carey M. The enhanceosome and transcriptional synergy. Cell 1998, 92:5-8.
109. Shirakawa F., Saito K., Bonagura C.A., Galson D.L., Fenton M.J., Webb A.C., et al. The human prointerleukin 1β gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol Cell Biol 1993, 13:1332-1344.
110. Tirosh I., Barkai N., Verstrepen K.J. Promoter architecture and the evolvability of gene expression. J Biol 2009, 8:95.
111. Oettgen P. Regulation of vascular inflammation and remodeling by ETS factors. Circ Res 2006, 99:1159-1166.
112. Tenen D.G., Hromas R., Licht J.D., Zhang D.E. Transcription factors, normal myeloid development, and leukemia. Blood 1997, 90:489-519.
113. Ghisletti S., Barozzi I., Mietton F., Polletti S., De Santa F., Venturini E., et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010, 32:317-328.
114. Heinz S., Benner C., Spann N., Bertolino E., Lin Y.C., Laslo P., et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 2010, 38:576-589.
115. Yang Z., Wara A.N., Chen C., Tsukada J., Auron P.E. NF-IL6 (C/EBPβ) vigorously activates il1b gene expression via a Spi-1 (PU.1) protein-protein tether. J Biol Chem 2000, 275:21272-21277.
116. Behre G., Whitmarsh A.J., Coghlan M.P., Hoang T., Carpenter C.L., Zhang D.E., et al. C-Jun is a JNK-independent coactivator of the PU.1 transcription factor. J Biol Chem 1999, 274:4939-4946.
117. Grondin B., Lefrancois M., Tremblay M., Saint-Denis M., Haman A., Waga K., et al. C-Jun homodimers can function as a context-specific coactivator. Mol Cell Biol 2007, 27:2919-2933.
118. Tissieres P., Araud T., Ochoda A., Drifte G., Dunn-Siegrist I., Pugin J. Cooperation between PU.1 and CAAT/enhancer-binding protein beta is necessary to induce the expression of the MD-2 gene. J Biol Chem 2009, 284:26261-26272.
119. Suh H.C., Gooya J., Renn K., Friedman A.D., Johnson P.F., Keller J.R. C/EBPalpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation. Blood 2006, 107:4308-4316.
120. Hsu C.L., King-Fleischman A.G., Lai A.Y., Matsumoto Y., Weissman I.L., Kondo M. Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors. Proc Natl Acad Sci USA 2006, 103:672-677.
121. Xie H., Ye M., Feng R., Graf T. Stepwise reprogramming of B cells into macrophages. Cell 2004, 117:663-676.
122. Laiosa C.V., Stadtfeld M., Xie H., de Andres-Aguayo L., Graf T. Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity 2006, 25:731-744.
123. Feng R., Desbordes S.C., Xie H., Tillo E.S., Pixley F., Stanley E.R., et al. PU.1 and C/EBPalpha/beta convert fibroblasts into macrophage-like cells. Proc Natl Acad Sci USA 2008, 105:6057-6062.
124. Pham T.H., Langmann S., Schwarzfischer L., El Chartouni C., Lichtinger M., Klug M., et al. CCAAT enhancer-binding protein beta regulates constitutive gene expression during late stages of monocyte to macrophage differentiation. J Biol Chem 2007, 282:21924-21933.
125. Yeamans C., Wang D., Paz-Priel I., Torbett B.E., Tenen D.G., Friedman A.D. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. Blood 2007, 110:3136-3142.
126. Lu Y.C., Kim I., Lye E., Shen F., Suzuki N., Suzuki S., et al. Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J Immunol 2009, 182:7212-7221.
127. Tanaka T., Akira S., Yoshida K., Umemoto M., Yoneda Y., Shirafuji N., et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 1995, 80:353-361.
128. Tanaka T., Yoshida N., Kishimoto T., Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J 1997, 16:7432-7443.
129. Landschulz W.H., Johnson P.F., McKnight S.L. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 1988, 240:1759-1764.
130. Lefterova M.I., Zhang Y., Steger D.J., Schupp M., Schug J., Cristancho A., et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008, 22:2941-2952.
131. Eyholzer M., Schmid S., Schardt J.A., Haefliger S., Mueller B.U., Pabst T. Complexity of miR-223 regulation by CEBPA in human AML. Leuk Res 2010, 34:672-676.
132. Eyholzer M., Schmid S., Wilkens L., Mueller B.U., Pabst T. The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. Br J Cancer 2010, 103:275-284.
133. Xi S., Yang M., Tao Y., Xu H., Shan J., Inchauste S., et al. Cigarette smoke induces C/EBP-beta-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS One 2010, 5:e13764.
134. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-alpha-PU.1 pathway. Nat Med Epub ahead of print.
135. Simonis M., Kooren J., de Laat W. An evaluation of 3C-based methods to capture DNA interactions. Nat Methods 2007, 4:895-901.
136. Schneider T.D., Stephens R.M. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 1990, 18:6097-6100.
137. Chinery R., Brockman J.A., Dransfield D.T., Coffey R.J. Antioxidant-induced nuclear translocation of CCAAT/Enhancer-binding Protein beta. J Biol Chem 1997, 272:30356-30361.